Clinical evaluation of combined azacitidine and entinostat on the induction of fetal hemoglobin in patients with acute myeloid leukemias and myelodysplastic syndromes

Katharine R. PressDepartment of Pediatrics, Columbia University Medical Center, NY, USA;

Natalie UyDeptartment of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT, USA;

Jeffrey KeeferJohns Hopkins University School of Medicine, Baltimore, MD, USA;

Steven D. GoreDeptartment of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT, USA;

Hetty E. CarrawayTaussig Cancer Institute, Hematologic Oncology and Blood Disorders, Cleveland Clinic, Cleveland, OH, USA

Sarah SakoianJohns Hopkins University School of Medicine, Baltimore, MD, USA;

Thomas PrebetDeptartment of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT, USA; Correspondence[email protected]

http://orcid.org/0000-0002-6872-625X

show all

Click to increase image sizeClick to decrease image size

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2017.1354373.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Clinical evaluation of combined azacitidine and entinostat on the induction of fetal hemoglobin in patients with acute myeloid leukemias and myelodysplastic syndromes

Information for

Open access

Opportunities

Help and information

Clinical evaluation of combined azacitidine and entinostat on the induction of fetal hemoglobin in patients with acute myeloid leukemias and myelodysplastic syndromes

Potential conflict of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature